Cold agglutinin disease (CAD) usually develops as a result of the production of a specific immunoglobulin M auto-antibody directed against the I/i and H antigens, precursors of the ABH and Lewis blood group substances, on red blood cells.
Introduction
Autoimmune hemolytic anemia (AIHA) is a complex process characterized by an immune reaction against red blood cell self-antigens. AIHA is classified into warm and cold reactive antibody types. 1 Cold agglutinin disease (CAD) has traditionally been classified into a primary or idiopathic type not associated with lymphoma or other diseases and a secondary type accompanied by malignant disease, most often lymphoma. 2 The term "cold" is primarily derived from the immune biology of CAD, not from clinical features of patients. The autoantibodies responsible for hemagglutination at low temperatures, cold agglutinins (CA), bind to erythrocyte carbohydrate antigens at a temperature optimum of 0 -4°C. Binding of CA causes agglutination of erythrocytes and the antigen-antibody complex induces complement-mediated hemolysis. Essential clinical manifestations of primary CAD are hemolytic anemia and cold-induced circulatory symptoms. 3 We report an interesting case of cold agglutinin disease in a patient who presented with hemolytic anemia and bilateral papillodema. The case emphasized various clinical presentation of cold agglutinin disease.
Case summary
A 26 year female presented with fever for 10 days, jaundice and fatigue for 2 months. She was advised for blood transfusion but on repeated attempts at local hospitals her blood group could not be determined. She enjoyed good health before this and no history of previous jaundice, Raynaud's phenomenon and other features suggestive of hemolysis during winter were present. None of her family members had suffered from similar symptoms before.
Clinical examination revealed severe pallor, mild jaundice, hepatosplenomegaly and examination of fundus showed, number of Roth's spots, hemorrhages and bilateral papilloedema, without lymphadenopathy or any other evidence of infection. The blood count showed: Leukocyte 8.86x10 9 /L, Hemoglobin 2.3gm/dl, MCV-168 fl, MCH-63.9 pg, MCHC-42.6 g/dL, Platelet count 1.84x10 9 /L, ESR-85mm in 1 st hour. PBF showed features suggestive of cold agglutinin disease. Leukocyte-7.91x10 9 /L, Hemoglobin-3.9gmldL, MCV122fl, RBC-reduced in number, plenty of polychromatic cell, nucleated red cell, few spherocytes and reduced agglutination.
by prewarming the samples to 37 o C before feeding them into the analyzer. 8 Bilirubin is mildly elevated and it is rarely more than 3 mg/dl. 7 The direct antiglobulin test is positive with polyspecific and anti compliment anti-sera. 9 Patients with high titres or wide thermal amplitude antibodies can pose extremely difficult serological problems for the blood bank laboratories, which happened in the present case. Often, incompatible units are released due to the residual agglutination from the cold auto-antibody. 7 These problems can be overcome by washing the patients' cells with warm saline in the direct grouping and by using normal AB positive serum on the control slide. 8 The paradox in CAD is the exacerbations that occur during febrile illnesses, which were seen in our patient.The other differential diagnoses which can be considered are paroxsysmal nocturnal haemoglobinuriaand cryoglobulinaemia. 6, 7 In the present case, a 26-year female presented with fever for 10 days and jaundice for 2 months, with hepatomegaly and splenomegaly and hemorrhages, Roth's spots and bilateral papilloedema on fundoscopy without any visual or neurological abnormalities. No history of previous acrocyanosis and no evidence of infection could be established in her case. The haemogram showed erratic values of the RBC count and the blood indices. The peripheral blood smear showed the spontaneous agglutination of RBCs, with normal WBC and platelets. This problem was encountered while the patient's blood group was being determined, due to the spontaneous agglutination on the slide. So, this we report as an unusual presentation of CAD and was one of the rare cases seen in our settings.
Conclusion
CAD is not an indolent disease in terms of the major clinical symptoms and the quality of life. The plethora of problems that occur during the laboratory testing of CAD should be known to the pathologist to make an early and accurate diagnosis. We also wish to highlight that there might be uncommon presentations of CAD as in this case papilloedema which couldn't be otherwise demonstrated. Physicians need to keep a high index of suspicion to suspect CAD with various presentations in such patients. The recent treatment modalities which use rituximab and fludaribine have shown good results, thus emphasizing the need for an early diagnosis of CAD. A diagnosis of primary CAD was made. Patient refused to go for bone marrow examination and other investigation workup. She has been started on steroids as she got discharged against medical advice and agreed to follow up after 2weeks.
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Discussion
The incidence of AIHA is estimated to be approximately 1:100,000 in adults. 4 Among these, warm-reactive antibodies are responsible for 87% of the cases and cold reactive antibodies are responsible for 13% of the cases. 4 Cold agglutinins (CAs) were first described by Landsteiner in 1903. 5 In warm AIHA, the sequestration mainly occurs in the spleen, in contrast in CAD sequestration occurs primarily in the liver. 6 Mild, chronic hemolytic anaemia exacerbates in the winter, which is a general rule for CAD. 7 Acrocyanosis occurs due to the agglutination of cells in the cooler vessels of the hands and feet. The first suspicion of CAD comes from the haematology laboratory's failed attempts to obtain a meaningful RBC count and indices. 7 The RBC counts are decreased and MCV is falsely elevated, producing an unbelievably high MCHC. 7 This problem can be avoided
